Vivos RDGL
OTC RDGL
$0.05 +0.01 (+25.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Vivos (RDGL) Gains from Sales and Divestitures (2017)

Updated

Vivos (RDGL) posted Gains from Sales and Divestitures of $2,800 for FY2017.

Analysis

Vivos (RDGL) Gains from Sales and Divestitures (2017) Analysis & Trends

  • The FY2017 figure stands as the highest annual Gains from Sales and Divestitures since FY2010.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn
10 Vivos 22.77 Mn 13.09 Mn -3,105.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2017 2,800.00
API Access

Vivos Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=RDGL&period=max&api_key=YOUR_API_KEY